Index S&P 500
P/E 30.43
EPS (ttm) 2.97
Insider Own 0.07%
Shs Outstand 1.31B
Perf Week 1.66%
Market Cap 115.99B
Forward P/E 15.46
EPS next Y 5.85
Insider Trans -2.18%
Shs Float 1.28B
Perf Month 10.24%
Income 3.93B
PEG 5.53
EPS next Q 1.25
Inst Own 87.30%
Short Float 1.16%
Perf Quarter 8.78%
Sales 32.58B
P/S 3.56
EPS this Y 4.87%
Inst Trans 1.50%
Short Ratio 2.35
Perf Half Y 5.78%
Book/sh 37.39
P/B 2.42
EPS next Y 7.29%
ROA 4.35%
Short Interest 14.84M
Perf Year 13.11%
Cash/sh 6.12
P/C 14.79
EPS next 5Y 5.51%
ROE 7.92%
52W Range 68.84 - 91.49
Perf YTD 9.78%
Dividend Est. 2.74 (3.02%)
P/FCF 22.54
EPS past 5Y -4.12%
ROI 5.29%
52W High -1.15%
Beta 0.84
Dividend TTM 2.77 (3.06%)
Quick Ratio 1.61
Sales past 5Y 1.24%
Gross Margin 60.13%
52W Low 31.38%
ATR (14) 1.57
Dividend Ex-Date Sep 27, 2024
Current Ratio 2.13
EPS Y/Y TTM 9.45%
Oper. Margin 17.95%
RSI (14) 69.27
Volatility 1.92% 1.80%
Employees 95000
Debt/Eq 0.58
Sales Y/Y TTM 3.23%
Profit Margin 12.05%
Recom 2.38
Target Price 93.52
Option/Short Yes / Yes
LT Debt/Eq 0.55
EPS Q/Q 35.53%
Payout 99.87%
Rel Volume 0.65
Prev Close 90.62
Sales Surprise 1.33%
EPS Surprise 2.59%
Sales Q/Q 2.77%
Earnings Aug 20 BMO
Avg Volume 6.33M
Price 90.44
SMA20 3.92%
SMA50 9.82%
SMA200 9.06%
Trades
Volume 2,117,567
Change -0.20%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-21-24 Reiterated
Oppenheimer
Perform
$92 → $94
Aug-15-24 Upgrade
UBS
Sell → Neutral
$76 → $90
Aug-14-24 Downgrade
Stifel
Buy → Hold
$100 → $85
May-30-24 Initiated
Goldman
Sell
$83
Jul-19-23 Initiated
Robert W. Baird
Neutral
$90
Jun-30-23 Initiated
CL King
Buy
$106
May-30-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$104
Apr-24-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$77 → $100
Mar-29-23 Downgrade
UBS
Buy → Sell
$127 → $79
Jan-09-23 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$102 → $89
Nov-23-22 Downgrade
Oppenheimer
Outperform → Perform
$106 → $85
Nov-23-22 Downgrade
Citigroup
Buy → Neutral
$108 → $85
Nov-16-22 Downgrade
Deutsche Bank
Buy → Hold
$85
Oct-18-22 Initiated
Barclays
Equal Weight
$90
Oct-13-22 Initiated
Mizuho
Buy
$100
Oct-12-22 Initiated
Jefferies
Hold
$87
Aug-24-22 Downgrade
Raymond James
Outperform → Mkt Perform
Jul-06-22 Initiated
Wolfe Research
Underperform
$85
Jun-01-22 Downgrade
Atlantic Equities
Overweight → Neutral
$125 → $105
May-27-22 Downgrade
Needham
Buy → Hold
Show Previous Ratings
Sep-08-24 10:01AM
Sep-05-24 06:00AM
Sep-04-24 06:19AM
Sep-03-24 04:32AM
01:21AM
06:53AM
Loading…
Sep-02-24 06:53AM
Sep-01-24 08:45AM
Aug-30-24 06:00AM
Aug-28-24 06:58PM
Aug-27-24 07:02PM
03:58PM
(Design & Development Today)
Aug-26-24 09:00AM
Aug-24-24 02:03PM
Aug-21-24 06:31AM
04:04AM
04:04PM
Loading…
Aug-20-24 04:04PM
(Investor's Business Daily)
03:49PM
03:45PM
02:48PM
02:30PM
01:30PM
12:11PM
11:45AM
11:37AM
11:29AM
11:26AM
09:30AM
07:55AM
07:12AM
(Investor's Business Daily)
07:02AM
07:02AM
Loading…
07:02AM
06:53AM
(Associated Press Finance)
06:45AM
Aug-19-24 04:49PM
11:18AM
10:12AM
09:30AM
09:00AM
07:53AM
05:52AM
Aug-18-24 08:30AM
Aug-17-24 10:17PM
09:05AM
Aug-16-24 07:00AM
Aug-15-24 02:06PM
12:32PM
10:20AM
09:15AM
03:00AM
Aug-14-24 04:23PM
11:42AM
10:58AM
09:50AM
Aug-13-24 05:45PM
01:45AM
Aug-12-24 08:29PM
06:00PM
04:20PM
03:01PM
10:53AM
Aug-08-24 07:13AM
04:52AM
Aug-07-24 04:57PM
08:07AM
08:00AM
02:45AM
Aug-06-24 05:45PM
04:16PM
07:07AM
Aug-02-24 08:00AM
(Investor's Business Daily)
Jul-31-24 05:45PM
12:30PM
Jul-30-24 05:15PM
Jul-29-24 05:50PM
04:30PM
Jul-26-24 10:00AM
Jul-25-24 12:30PM
(The Wall Street Journal)
Jul-23-24 09:40AM
07:30AM
Jul-22-24 05:50PM
05:20AM
Jul-20-24 08:45PM
Jul-19-24 11:33AM
09:00AM
Jul-18-24 02:09PM
10:30AM
06:15AM
Jul-17-24 04:05PM
02:29PM
Jul-16-24 05:50PM
02:00PM
12:30PM
10:20AM
08:26AM
Jul-15-24 05:44AM
Jul-14-24 09:31AM
Jul-13-24 11:00AM
10:06AM
06:26AM
Jul-11-24 02:02PM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PARKHILL KAREN L Former Officer Aug 26 '24 Proposed Sale 90.00 2,668 240,120 Aug 26 02:11 PM Wall Brett A. EVP & Pres Neuroscience Aug 02 '24 Option Exercise 0.00 5,311 0 49,169 Aug 06 06:16 PM Walter Matthew R. SVP, Chief HR Officer Aug 02 '24 Option Exercise 0.00 684 0 25,889 Aug 06 06:15 PM Smith Gregory L EVP Global Ops & Supply Chain Aug 02 '24 Option Exercise 0.00 3,490 0 64,757 Aug 06 06:14 PM Salmon Sean EVP & President Cardiovascular Aug 02 '24 Option Exercise 0.00 5,462 0 68,546 Aug 06 06:14 PM PARKHILL KAREN L EVP & Chief Financial Officer Aug 02 '24 Option Exercise 0.00 7,132 0 53,459 Aug 06 06:13 PM Martha Geoffrey Chairman and CEO Aug 02 '24 Option Exercise 0.00 18,966 0 203,086 Aug 06 06:13 PM Marinaro Michael EVP & President, Surgical OU Aug 02 '24 Option Exercise 0.00 1,670 0 43,801 Aug 06 06:12 PM Kirk Jennifer M Chief Accounting Officer Aug 02 '24 Option Exercise 0.00 1,138 0 28,980 Aug 06 06:12 PM Fong Ivan K EVP GENERAL COUNSEL & SECR Aug 02 '24 Option Exercise 0.00 14,514 0 63,750 Aug 06 06:11 PM Walter Matthew R. SVP, Chief HR Officer Jul 18 '24 Option Exercise 62.76 492 30,878 17,580 Jul 19 04:40 PM Martha Geoffrey Chairman and CEO Jun 07 '24 Option Exercise 62.76 19,113 1,199,532 162,461 Jun 11 06:53 PM Martha Geoffrey Chairman and CEO Jun 07 '24 Sale 83.77 19,113 1,601,001 143,348 Jun 11 06:53 PM Marinaro Michael EVP & President, Surgical OU Apr 08 '24 Sale 83.14 854 71,002 27,925 Apr 09 04:08 PM Salmon Sean EVP & President Cardiovascular Feb 21 '24 Option Exercise 69.07 30,695 2,120,121 78,984 Feb 23 05:18 PM Salmon Sean EVP & President Cardiovascular Feb 21 '24 Sale 85.13 30,695 2,613,055 48,289 Feb 23 05:18 PM Wall Brett A. EVP & Pres Neuroscience Dec 19 '23 Sale 82.17 4,997 410,603 28,910 Dec 20 11:41 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite